Table 2 Organism-wise antibiotic resistance pattern
Antibiotics | Isolates | ||||||
|---|---|---|---|---|---|---|---|
E. coli (n = 29) | K. pneumoniae (n = 35) | P. aeruginosa (n = 6) | Acinetobacter (n = 14) | Enterobacter (n = 2) | P. mirabilis (n = 2) | S. marcecens (n = 4) | |
Amoxycillin | 100.0% | 94.3% | 100.0% | 100.0% | 100.0% | 100.0% | 75.0% |
Amikacin | 34.5% | 77.1% | 50.0% | 78.6% | 100.0% | 0.0% | 50.0% |
Cipofloxacin | 96.6% | 88.6% | 66.7% | 100.0% | 0.0% | 100.0% | 50.0% |
Cotrimoxazole | 65.5% | 60.0% | 100.0% | 100.0% | 100.0% | 50.0% | 50.0% |
Gentamicin | 27.6% | 80.0% | 83.3% | 78.6% | 0.0% | 50.0% | 0.0% |
Malidixic acid | 100.0% | 97.1% | 100.0% | 92.9% | 100.0% | 100.0% | 25.0% |
Polymyxin B | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Ofloxacin | 96.6% | 88.6% | 66.7% | 100.0% | 0.0% | 100.0% | 50.0% |
Amoxyclav | 79.3% | 85.7% | 100.0% | 92.9% | 100.0% | 100.0% | 0.0% |
Ceftriaxone | 86.2% | 91.4% | 83.3% | 92.9% | 0.0% | 0.0% | 50.0% |
Cefixime | 100.0% | 91.4% | 100.0% | 100.0% | 0.0% | 0.0% | 25.0% |
Ceftazidime | 89.7% | 91.4% | 83.3% | 100.0% | 100.0% | 0.0% | 50.0% |
Piperacillin tazobactam | 20.7% | 77.1% | 50.0% | 78.6% | 0.0% | 50.0% | 0.0% |
Tobramycin | 44.4% | 80.0% | 40.0% | 78.6% | - | - | - |
Cefepime | 93.1% | 91.4% | 50.0% | 85.7% | 100.0% | 50.0% | 25.0% |
Meropenem | 24.1% | 60.0% | 50.0% | 64.3% | 0.0% | 0.0% | 0.0% |
Imipenem | 20.7% | 57.1% | 50.0% | 78.6% | 0.0% | 0.0% | 25.0% |
Nitrofurantoin | 24.1% | 74.3% | - | 85.7% | 100.0% | 100.0% | 50.0% |
Norfloxacin | 96.6% | 88.6% | 66.7% | 100.0% | 0.0% | 100.0% | 50.0% |
Cephodoxime | 93.1% | 100.0% | 83.3% | 78.6% | 100.0% | 100.0% | 50.0% |